YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Drugmaker Valeant selling over $1.3B in assets

Posted online
Valeant Pharmaceuticals International intends to sell three of its skin care brands to French cosmetics company L'Oreal for $1.3 billion.

The proposed sale was announced a day after Valeant officials said the company will sell its Dendreon cancer unit to China conglomerate Sanpower Group for $819.9 million.

The moves are part of Valeant CEO Joseph Papa's plan to cut the drugmaker's estimated $30 million in debt.

Read more from USA Today.


Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences